Patent details

Basic Information

Publication number:

EP1505977

PCT Application Number:

PCT/US/2003/016277

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP037554466

PCT Publication Number:

WO/2003/099281

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ADMINISTRATION OF A PARTIAL FATTY ACID OXIDATION INHIBITOR SUCH AS RANOLAZINE FOR THE TREATMENT OF DIABETES

French Title of Invention:

ADMINISTRATION D'UN INHIBITEUR PARTIEL DE L'OXIDATION DES ACIDES GRAS TEL QUE LA RANOLAZINE POUR LE TRAITEMENT DU DIABETE

German Title of Invention:

VERABREICHUNG EINES PARTIELLEN FETTSÄURE OXIDATIONSHEMMERS WIE RANOLAZIN ZUR BEHANDLUNG VON DIABETES

SPC Number:

Dates

Filing date:

21/05/2003

Grant date:

10/09/2014

EP Publication Date:

10/09/2014

PCT Publication Date:

04/12/2003

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/02/2005

EP B1 Publication Date:

10/09/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/05/2015

Expiration date:

21/05/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/05/2003

 

 

Name:

Gilead Sciences Inc.

Address:

333 Lakeside Drive, Foster City, CA 94404, United States (US)

Inventor

1

Name:

WOLFF Andrew

Address:

United States (US)

2

Name:

JERLING Markus

Address:

Sweden (SE)

Priority

1

Priority Number:

382781 P

Priority Date:

21/05/2002

Priority Country:

United States (US)

2

Priority Number:

459332 P

Priority Date:

31/03/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/495;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages